Dare Bioscience (DARE) Reports In-Line Q2 EPS

Dare Bioscience (NASDAQ: DARE) reported Q2 EPS of ($0.10), in-line with the analyst estimate of ($0.10).

For earnings history and earnings-related data on Dare Bioscience (DARE) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Exclusive: BitGo says institutional conversations are shifting to tokenization
• Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02